#OrigAMI4 - Twitter Hashtag

Amivantamab (SC) now @FDA✅ for 2L R/M HNSCC (HPV-unrelated) post plat + IO based on #OrigAMI4: - Ph1b/2, SC Ami mono (n=102) - ORR 42% (CR 15%). Historic 2L ORR 20-25% - mPFS 6.8mos, mOS 12.5mos - DoR NR (56% ≥6mo)! Much needed option. #OncTwittwer @OncUpdates @OncoAlert

OncBrothers's tweet photo. Amivantamab (SC) now @FDA✅ for 2L R/M HNSCC (HPV-unrelated) post plat + IO based on #OrigAMI4:

- Ph1b/2, SC Ami mono (n=102)
- ORR 42% (CR 15%). Historic 2L ORR 20-25%
- mPFS 6.8mos, mOS 12.5mos
- DoR NR (56% ≥6mo)! Much needed option.

#OncTwittwer @OncUpdates @OncoAlert https://t.co/l6IF5AJf9E

4

61

24

13

7K

Pablo Jiménez @PaulJiL

20 days ago

#ESMO26 is here with plenty of studies to digest in the Head & Neck space ⛳️Great interest in the potential addition of neo chemo to periop IO 📢Novel analyses from #KEYNOTE689 📡Cohort 5 from #Origami4 🎯Surge of several ADCs in ongoing research Here is my take👇 for #HNSCC #NPC #SalivaryGlandCancers #Sinonasal #headandneckcancer @myESMO @OncoAlert @brunolarvol @FundacionTTCC @SGCancerUK

PaulJiL's tweet photo. #ESMO26 is here with plenty of studies to digest in the Head & Neck space

⛳️Great interest in the potential addition of neo chemo to periop IO
📢Novel analyses from #KEYNOTE689
📡Cohort 5 from #Origami4
🎯Surge of several ADCs in ongoing research

Here is my take👇 for #HNSCC #NPC #SalivaryGlandCancers #Sinonasal

#headandneckcancer
@myESMO @OncoAlert @brunolarvol
@FundacionTTCC @SGCancerUK

0

5

4

1

630

Oncology Brothers

@OncBrothers

5 months ago

Head & Neck Cancer and Sarcoma Conference Highlights from #ASCO26 w/ @AriRosenbergMD & @TwoOncDocs (Sam) ✅ Abstract 6004 ✅ #OrigAMI4 ✅ #SARC041 ✅ #PEAK Full 🗣️ ⭐️ “Oncology Brothers” podcast ⭐️ https://t.co/qd6HOmj3lR #OncTwitter #MedTwitter #hncsm @OncUpdates